Current use of oral menopausal hormone therapy (commonly known as hormone replacement therapy or HRT) is associated with an increased risk of blood clots in the legs or lungs regardless of dose or treatment duration, finds a large Danish study published by The BMJ.
Oral Menopausal Hormone Therapy Increases Blood Clot Risk, Transdermal Treatment Safe
A large Danish study published in The BMJ has found that current use of oral menopausal hormone therapy is linked to a higher risk of blood clots, regardless of dosage or duration. This finding is significant for healthcare practices in Iran, where hormone replacement therapy may be commonly prescribed. Understanding these risks is crucial for patient safety and healthcare guidelines.
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%